MODULATION OF PROTEIN EXPRESSION USING CARBOCYCLIC ARYL ALKENOIC ACID DERIVATIVES

Title:

MODULATION OF PROTEIN EXPRESSION USING CARBOCYCLIC ARYL ALKENOIC ACID DERIVATIVES

Document Type and Number:

WIPO Patent Application WO2000053174

Kind Code:

A9

Abstract:

The present invention generally relates to diseases or conditions modulated by undesired protein expression. In one aspect, the methods provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a carbocyclic aryl compound capable of modulating that undesired protein expression. Assays for detecting compounds having desired therapeutic capacity are also provided.

More Like This:

WO/2023/150926	A FEED COMPOSITION AND USE THEREOF
JP2022551504	Pharmaceutical compositions based on micronized drug resinates and methods for their preparation
WO/2003/009778	METHODS AND DEVICES FOR DELIVERY OF THERAPEUTIC CAPABLE AGENTS WITH VARIABLE RELEASE PROFILE

Inventors:

ZEITLIN PAMELA L
BRUSILOW SAUL

Application Number:

PCT/US2000/006377

Publication Date:

May 10, 2002

Filing Date:

March 11, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV JOHNS HOPKINS (US)

International Classes:

A61K31/192; (IPC1-7): A61K31/235; A61K31/165; A61K31/19; A61K31/24

Download PDF:

View/Download PDF PDF Help

Previous Patent: USE OF METFORMIN IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CAPABLE OF INHIBITING THE ENZYME ...

Next Patent: PHARMACEUTIC, DIETETIC AND COSMETIC COMPOSITIONS BASED ON THIOCTIC ACID AND CYSTEINE